Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Venous Thromboembolism 1TP53 Y220C Mutation 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pulmonary Embolism 1Prostatic Neoplasms, Castration-Resistant 1Peripheral Nervous System Diseases 1Neoplasms 1Liver Cirrhosis 1Leiomyosarcoma 1Healthy Participants 1Healthy Adult Participants 1Endometrial Neoplasms 1Drug-drug Interaction,SHR3680 1Cardiotoxicity 1Breast Neoplasms 1Advanced Solid Malignancies 1

Interventions

pembrolizumab 45Paclitaxel 42Carboplatin 34Bevacizumab 18Specimen Handling 17Letrozole 16lenvatinib 13Magnetic Resonance Spectroscopy 12dostarlimab 11Cisplatin 11Biopsy 11Taxes 10olaparib 9Fulvestrant 9Doxorubicin 9abemaciclib 8Megestrol Acetate 8Docetaxel 8durvalumab 7atezolizumab 7Nivolumab 7Gemcitabine 7Blood Specimen Collection 7palbociclib 6Oxaliplatin 6Observation 6Fluorouracil 6niraparib 5Surveys and Questionnaires 5Progestins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Rosuvastatin Calcium × 1 year × Clear all
NCT04491643 2025-08-11

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Fudan University

Phase 2 Completed
48 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡